RESEARCH PHILOSOPHY
Soy Labs’ core corporate value is transforming innovative science into high quality nutritional products. We emphasize strong basic research with an acute focus on the major health and wellness concerns facing society today such as heart disease, obesity, diabetes, osteoporosis, menopause, cancer and successful aging.

Our Research and Development roadmap includes research projects with foresight into the future health needs of today’s consumer as well as expanding the research portfolio of our current products.

Continuous clinical trials are the key to the exploration and discovery of new ingredients and formulations that may make a significant difference in the future of preventable societal health challenges. We are currently conducting several national and international human clinical trials on heart health and weight loss. The scientific advisory board of the Research Department here at Soy Labs collaborates with both national and internationally renowned scientists at leading universities and medical centers. Our continuous work covers an array of innovative scientific activities and discourse regarding the latest in research findings.

RESEARCH HIGHLIGHTS
The latest human clinical study on CardioTrim® studied the effects of the proprietary CORE™ formula (found within the CardioTrim line) on various parameters for weight loss and cardiovascular health. The double-blind placebo-controlled study tested 123 overweight or obese individuals over the course of 8 weeks. The obese subjects were divided into three testing groups: CardioTrim plus diet (2100-2200kcal per day), CardioTrim without diet, and Placebo group who also did not follow a structured diet. The study protocol called for the subjects who were taking the CardioTrim CORE formula to take one capsule twice daily, and the placebo group took a placebo pill twice daily as well. The data findings for the study parameters are as follows:

Heart Disease/Cardiovascular Support:

Studies have looked at the CardioTrim CORE formula role in reducing total cholesterol levels, triglycerides and lowering blood pressure.

Weight Loss/Obesity:

Our latest research on the CORE formula as it relates to obesity and weight loss shows that obese individuals lost an average of 8.1- 17.8 lbs. over 8 weeks.

Diabetes/Fasting Blood Glucose:

Effective diabetes management involves not only daily blood sugar control, but also paying attention to heart disease risk factors such as cholesterol and triglyceride levels because 2/3 of all diabetics will develop heart disease in the future. Both AlbumaSoy and Cissus have α-amylase inhibiting activity indicating the blocking of the absorption of carbohydrates and managing blood sugar control. Our CORE formula lowered fasting blood glucose levels by 12.8-16.8%.